Who
Brent Sabatini
SVP, Chief Accounting Officer
Company insider
Files Form 4 as: SVP, Chief Accounting Officer, Vir Biotechnology.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $255K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Feb 2025
- Last trade
- 1 Jun 2026
- Last filed
- 2 Jun 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 2 Jun 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $3,582379 at $9.45 | filing |
| 1 Jun 2026filed 2 Jun 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $3,582379 at $9.45 | filing |
| 23 Mar 2026filed 24 Mar 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $70K7,711 at $9.12 | filing |
| 23 Mar 2026filed 24 Mar 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $70K7,711 at $9.12 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $14K1,430 at $9.53 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $14K1,430 at $9.53 | filing |
| 23 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $14K1,829 at $7.45 | filing |
| 23 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $14K1,829 at $7.45 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $12K1,530 at $7.79 | filing |
| 13 Feb 2026filed 18 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $12K1,530 at $7.79 | filing |
| 24 Feb 2025filed 25 Feb 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $15K1,562 at $9.45 | filing |
| 22 Feb 2025filed 25 Feb 2025 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 22 Feb 2025filed 25 Feb 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 13 Feb 2025filed 14 Feb 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $14K1,562 at $9.15 | filing |
News
Vir Biotechnology (NASDAQ:VIR) Reaches New 12-Month High – Here's What HappenedVIR · tickerreport.com · 12 Oct 2026Vir Biotechnology (NASDAQ:VIR) vs. uniQure (NASDAQ:QURE) Critical ContrastVIR · dailypolitical.com · 11 Oct 2026Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $22.00VIR · tickerreport.com · 10 Oct 2026
0 headlines in the last 90 days name Brent Sabatini; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.